Dornase-alfa and orphan drugs

Virtual Nursing in Residential Aged Care: What Is Known? A Rapid Review.

Journal of advanced nursing·2025

The structure of liquid carbon elucidated by in situ X-ray diffraction.

Nature·2025

Neglect-like symptoms and their relationships with other clinical features in people with hand osteoarthritis: An exploratory study.

Musculoskeletal science & practice·2022

Steroids to reduce the impact on delirium (STRIDE): a double-blind, randomised, placebo-controlled feasibility trial of pre-operative dexamethasone in people with hip fracture.

Anaesthesia·2021

Performance comparison of Yb:YAG ceramics and crystal gain material in a large-area, high-energy, high average-power diode-pumped laser.

Optics express·2020

Orbital Angular Momentum Coupling in Elastic Photon-Photon Scattering.

Physical review letters·2019

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

The Lancet regional health. Europe·2026

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

Therapeutic innovation & regulatory science·2026

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.

The Journal of dermatological treatment·2026

Coexistence of primary aldosteronism and micro-pheochromocytoma: a case report with pathological analysis and literature review.

Frontiers in medicine·2026

From incident response to system design: Japan's 2025 PMD Act drug-shortage reform.

Health policy (Amsterdam, Netherlands)·2026

Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013-19.

Health affairs (Project Hope)·2026

Related Experiment Videos

Dornase-alfa and orphan drugs

Related Concept Videos

Virtual Nursing in Residential Aged Care: What Is Known? A Rapid Review.

The structure of liquid carbon elucidated by in situ X-ray diffraction.

Neglect-like symptoms and their relationships with other clinical features in people with hand osteoarthritis: An exploratory study.

Steroids to reduce the impact on delirium (STRIDE): a double-blind, randomised, placebo-controlled feasibility trial of pre-operative dexamethasone in people with hip fracture.

Performance comparison of Yb:YAG ceramics and crystal gain material in a large-area, high-energy, high average-power diode-pumped laser.

Orbital Angular Momentum Coupling in Elastic Photon-Photon Scattering.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.

Clinical characteristics and outcomes of paradoxical palmoplantar pustulosis during secukinumab therapy in biologic-naïve patients with plaque psoriasis: a retrospective case series.

Coexistence of primary aldosteronism and micro-pheochromocytoma: a case report with pathological analysis and literature review.

From incident response to system design: Japan's 2025 PMD Act drug-shortage reform.

Highly Novel Drugs Outperformed Less Novel Drugs In Gross And Net Revenues In The US, Driven Primarily By Utilization, 2013-19.

Related Experiment Videos

Dornase-alfa and orphan drugs

Related Concept Videos

Related Articles